Skip to main content
Amphastar Pharmaceuticals, Inc. logo

Amphastar Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · AMPH ISIN · US03209R1032 LEI · 54930055TH0ZLSAQMJ38 US Manufacturing
Open in API
Filings indexed 918 across all filing types
Latest filing 2014-05-14 Capital/Financing Update
Country US United States of America
Listing US AMPH

About Amphastar Pharmaceuticals, Inc.

https://amphastar.com/

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing technically challenging medications. Its portfolio includes generic and proprietary injectable, intranasal, and inhalation products. The company specializes in complex medications such as biologics derived from living cells, proteins, and interchangeable biosimilars. Amphastar also develops innovative drug delivery systems and proprietary technological platforms for various routes of administration.

Recent filings

Filing Released Lang Actions
Capital/Financing Update 2014
Capital/Financing Update Classification · 100% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It is a preliminary prospectus for Amphastar Pharmaceuticals, Inc.'s initial public offering of common stock. The text includes details about the offering, underwriting, risk factors, business overview, and other information typical of an IPO registration statement. This type of filing is related to capital raising and financing activities. Therefore, it fits the category of Capital/Financing Update (CAP). The document is not an annual or quarterly report, audit report, earnings release, or any other category defined. The length and content confirm it is a full registration statement, not just an announcement or certification.
2014-05-14 English
Regulatory Filings 2014
Regulatory Filings
2014-04-14 English
Capital/Financing Update 2014
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It is a preliminary prospectus for Amphastar Pharmaceuticals, Inc.'s initial public offering (IPO) of common stock. The text includes details about the offering, underwriting, risk factors, business overview, management, and financial data. This type of filing is a registration statement used to register securities for public sale and is not a financial report like an annual or quarterly report. It is also not an announcement or a proxy statement. Therefore, the filing type corresponds to a Capital/Financing Update (CAP), which covers company fundraising and financing activities such as IPOs.
2014-04-03 English
Regulatory Filings 2014
Regulatory Filings
2014-02-19 English
Capital/Financing Update 2014
Capital/Financing Update Classification · 95% confidence The document is a Form S-1 Registration Statement filed with the U.S. Securities and Exchange Commission. It is a preliminary prospectus for Amphastar Pharmaceuticals, Inc.'s initial public offering of common stock. The text includes details about the offering, underwriting, risk factors, business overview, and other information typical of an IPO registration statement. This type of filing is related to capital raising and financing activities. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it is not merely an announcement or a certification, but the actual registration statement/prospectus text. Hence, the correct classification is CAP with high confidence.
2014-02-07 English
Regulatory Filings 2014
Regulatory Filings
2014-01-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.